d-Glucosamine induces circadian phase delay by promoting BMAL1 degradation through AMPK/mTOR pathway

Zeqi Li,Bo Fu,Aili Wei,Yanchen Wu,Ming Huang,Enhao Zhang,Bo Cui,Bo Wang,Hui Peng
DOI: https://doi.org/10.1016/j.lfs.2023.121765
IF: 6.78
2023-05-11
Life Sciences
Abstract:Circadian rhythms are closely linked to the metabolic network through circadian feedback regulation. The hexosamine biosynthetic pathway (HBP) is a branch of glucose metabolism that affects circadian rhythms through the O-linked N -acetylglucosamine modification (O-GlcNAcylation) of clock proteins. Here, we found out that, among the downstream metabolites regulated by d -glucosamine (GlcN) in HBP salvage pathway, only GlcN is able to induce circadian phase delay both in vitro and in vivo . Mechanistic studies indicated that the phase-shift induced by GlcN is independent of O-GlcNAcylation. Instead, GlcN selectively up-regulates p-AMPK activity, leading to the inhibition of mTOR signaling pathway, and thus down-regulation of p-BMAL1 both in human cell line and mouse tissues. Moreover, GlcN promoted BMAL1 degradation via proteasome pathway. These findings reveal a novel molecular mechanism of GlcN in regulating clock phase and suggest the therapeutic potential of GlcN as new use for an old drug in the future treatment of shift work and circadian misalignment.
pharmacology & pharmacy,medicine, research & experimental
What problem does this paper attempt to address?